Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Baxdrostat [inn]
2. Nf3p9z8j5y
3. (+)-(r)-n-(4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide
4. 1428652-17-8
5. N-((8r)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)propanamide
6. Propanamide, N-((8r)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)-
7. Unii-nf3p9z8j5y
8. Chembl4113975
9. Schembl14799753
10. Bdbm233806
11. Hy-132809
12. Cs-0204056
13. Us9353081, 3-1
Molecular Weight | 363.5 g/mol |
---|---|
Molecular Formula | C22H25N3O2 |
XLogP3 | 2.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 363.19467705 g/mol |
Monoisotopic Mass | 363.19467705 g/mol |
Topological Polar Surface Area | 62.3 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 566 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Baxdrostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Baxdrostat, including repackagers and relabelers. The FDA regulates Baxdrostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Baxdrostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Baxdrostat supplier is an individual or a company that provides Baxdrostat active pharmaceutical ingredient (API) or Baxdrostat finished formulations upon request. The Baxdrostat suppliers may include Baxdrostat API manufacturers, exporters, distributors and traders.
Baxdrostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Baxdrostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Baxdrostat GMP manufacturer or Baxdrostat GMP API supplier for your needs.
A Baxdrostat CoA (Certificate of Analysis) is a formal document that attests to Baxdrostat's compliance with Baxdrostat specifications and serves as a tool for batch-level quality control.
Baxdrostat CoA mostly includes findings from lab analyses of a specific batch. For each Baxdrostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Baxdrostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Baxdrostat EP), Baxdrostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Baxdrostat USP).
LOOKING FOR A SUPPLIER?